Compare, Analyse Biocon Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TEVA PHARMA (Israel) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    TEVA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-19
TEVA PHARMA
Dec-13
BIOCON /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7073,149-   
Low Rs5542,736-   
Sales per share (Unadj.) Rs91.91,807.4-  
Earnings per share (Unadj.) Rs16.7112.9-  
Cash flow per share (Unadj.) Rs24.2259.0-  
Dividends per share (Unadj.) Rs1.0098.84-  
Dividend yield (eoy) %0.23.4 4.7%  
Book value per share (Unadj.) Rs101.62,007.7-  
Shares outstanding (eoy) m600.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.91.6 421.4%   
Avg P/E ratio x37.726.1 144.8%  
P/CF ratio (eoy) x26.111.4 229.6%  
Price / Book Value ratio x6.21.5 423.3%  
Dividend payout %6.087.5 6.8%   
Avg Mkt Cap Rs m378,3302,495,282 15.2%   
No. of employees `0006.144.9 13.6%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.334,101.5 26.4%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.32,130.3 76.8%   
INCOME DATA
Net Sales Rs m55,1441,532,691 3.6%  
Other income Rs m1,4440-   
Total revenues Rs m56,5881,532,691 3.7%   
Gross profit Rs m15,883419,728 3.8%  
Depreciation Rs m4,478123,889 3.6%   
Interest Rs m70930,105 2.4%   
Profit before tax Rs m12,140265,735 4.6%   
Minority Interest Rs m91,207 0.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-174,440 0.0%   
Tax Rs m2,123-3,244 -65.4%   
Profit after tax Rs m10,02695,746 10.5%  
Gross profit margin %28.827.4 105.2%  
Effective tax rate %17.5-1.2 -1,432.4%   
Net profit margin %18.26.2 291.0%  
BALANCE SHEET DATA
Current assets Rs m48,2281,035,174 4.7%   
Current liabilities Rs m30,376902,759 3.4%   
Net working cap to sales %32.48.6 374.7%  
Current ratio x1.61.1 138.5%  
Inventory Days Days6891 75.2%  
Debtors Days Days8696 89.1%  
Net fixed assets Rs m64,130500,611 12.8%   
Share capital Rs m3,0003,773 79.5%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,9801,702,529 3.6%   
Long term debt Rs m15,766783,699 2.0%   
Total assets Rs m121,9243,502,691 3.5%  
Interest coverage x18.19.8 184.4%   
Debt to equity ratio x0.30.5 56.2%  
Sales to assets ratio x0.50.4 103.4%   
Return on assets %8.83.6 245.1%  
Return on equity %16.45.6 292.4%  
Return on capital %16.84.9 339.7%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546244,232 4.7%  
From Investments Rs m-7,138-86,541 8.2%  
From Financial Activity Rs m-2,417-292,972 0.8%  
Net Cashflow Rs m2,103-135,282 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.45 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare BIOCON With: DR. DATSONS LABS  TORRENT PHARMA  PANACEA BIOTECH  VENUS REMEDIES  CADILA HEALTHCARE  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World (Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade? (Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Jun 5, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON - ALEMBIC LTD COMPARISON

COMPARE BIOCON WITH

OTHER USEFUL LINKS

MARKET STATS